166 related articles for article (PubMed ID: 27398979)
21. Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt.
Thabet M; Hemida R; Hasan M; Elshamy M; Elfaraash M; Emam M
J Exp Ther Oncol; 2014; 10(4):247-53. PubMed ID: 25509977
[TBL] [Abstract][Full Text] [Related]
22. Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.
Di Domenico F; De Marco F; Perluigi M
Expert Rev Proteomics; 2013 Oct; 10(5):461-72. PubMed ID: 24117203
[TBL] [Abstract][Full Text] [Related]
23. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
26. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis.
de Freitas AC; Coimbra EC; Leitão Mda C
Biochim Biophys Acta; 2014 Apr; 1845(2):91-103. PubMed ID: 24388872
[TBL] [Abstract][Full Text] [Related]
27. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
Nahand JS; Taghizadeh-Boroujeni S; Karimzadeh M; Borran S; Pourhanifeh MH; Moghoofei M; Bokharaei-Salim F; Karampoor S; Jafari A; Asemi Z; Tbibzadeh A; Namdar A; Mirzaei H
J Cell Physiol; 2019 Aug; 234(10):17064-17099. PubMed ID: 30891784
[TBL] [Abstract][Full Text] [Related]
28. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy.
Ripabelli G; Grasso GM; Del Riccio I; Tamburro M; Sammarco ML
Cancer Epidemiol; 2010 Apr; 34(2):162-7. PubMed ID: 20080070
[TBL] [Abstract][Full Text] [Related]
30. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
31. Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.
Martin CM; Kehoe L; Spillane CO; O'Leary JJ
Mol Diagn Ther; 2007; 11(5):277-90. PubMed ID: 17963416
[TBL] [Abstract][Full Text] [Related]
32. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
33. Role of cytokines in genesis, progression and prognosis of cervical cancer.
Paradkar PH; Joshi JV; Mertia PN; Agashe SV; Vaidya RA
Asian Pac J Cancer Prev; 2014; 15(9):3851-64. PubMed ID: 24935564
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?
Valenti G; Vitale SG; Tropea A; Biondi A; Laganà AS
Updates Surg; 2017 Dec; 69(4):441-449. PubMed ID: 28918603
[TBL] [Abstract][Full Text] [Related]
35. Understanding Cervical Cancer through Proteomics.
Martínez-Rodríguez F; Limones-González JE; Mendoza-Almanza B; Esparza-Ibarra EL; Gallegos-Flores PI; Ayala-Luján JL; Godina-González S; Salinas E; Mendoza-Almanza G
Cells; 2021 Jul; 10(8):. PubMed ID: 34440623
[TBL] [Abstract][Full Text] [Related]
36. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
37. How may targeted proteomics complement genomic data in breast cancer?
Guerin M; Gonçalves A; Toiron Y; Baudelet E; Audebert S; Boyer JB; Borg JP; Camoin L
Expert Rev Proteomics; 2017 Jan; 14(1):43-54. PubMed ID: 27813428
[TBL] [Abstract][Full Text] [Related]
38. Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification.
Bao H; Li X; Cao Z; Huang Z; Chen L; Wang M; Hu J; Li W; Sun H; Jiang X; Mei P; Li H; Lu L; Zhan M
J Transl Med; 2022 Jan; 20(1):18. PubMed ID: 34991628
[TBL] [Abstract][Full Text] [Related]
39. Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
Garg P; Krishna M; Subbalakshmi AR; Ramisetty S; Mohanty A; Kulkarni P; Horne D; Salgia R; Singhal SS
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189106. PubMed ID: 38701936
[TBL] [Abstract][Full Text] [Related]
40. In silico analysis of protein neoplastic biomarkers for cervix and uterine cancer.
Rodríguez-Pérez MA; Medina-Aunon A; Encarnación-Guevara SM; Bernal-Silvia S; Barrera-Saldaña H; Albar-Ramírez JP
Clin Transl Oncol; 2008 Oct; 10(10):604-17. PubMed ID: 18940741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
